Article Versions Notes

Principe L, Lupia T, Andriani L, Campanile F, Carcione D, Corcione S, De Rosa FG, Luzzati R, Stroffolini G, Steyde M, et al. Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians. Pharmaceuticals. 2022; 15(4):463. https://doi.org/10.3390/ph15040463

Principe, Luigi, Tommaso Lupia, Lilia Andriani, Floriana Campanile, Davide Carcione, Silvia Corcione, Francesco Giuseppe De Rosa, Roberto Luzzati, Giacomo Stroffolini, Marina Steyde, and et al. 2022. "Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians" Pharmaceuticals 15, no. 4: 463. https://doi.org/10.3390/ph15040463

Principe, L., Lupia, T., Andriani, L., Campanile, F., Carcione, D., Corcione, S., De Rosa, F. G., Luzzati, R., Stroffolini, G., Steyde, M., Decorti, G., & Di Bella, S. (2022). Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians. Pharmaceuticals, 15(4), 463. https://doi.org/10.3390/ph15040463